Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets
CW Spearman, M Afihene, R Ally, B Apica… - The lancet …, 2017 - thelancet.com
The WHO global health sector strategy on viral hepatitis, created in May, 2016, aims to
achieve a 90% reduction in new cases of chronic hepatitis B and C and a 65% reduction in …
achieve a 90% reduction in new cases of chronic hepatitis B and C and a 65% reduction in …
Prevalence and burden of HBV co‐infection among people living with HIV: a global systematic review and meta‐analysis
Globally, in 2017 35 million people were living with HIV (PLHIV) and 257 million had chronic
HBV infection (HBsAg positive). The extent of HIV‐HBsAg co‐infection is unknown. We …
HBV infection (HBsAg positive). The extent of HIV‐HBsAg co‐infection is unknown. We …
[HTML][HTML] The status of hepatitis B control in the African region
L Breakwell, C Tevi-Benissan, L Childs… - The Pan African …, 2017 - ncbi.nlm.nih.gov
Abstract The World Health Organization (WHO) African Region has approximately 100
million people with chronic hepatitis B virus (HBV) infection. This review describes the status …
million people with chronic hepatitis B virus (HBV) infection. This review describes the status …
[HTML][HTML] Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis
RE Barth, Q Huijgen, J Taljaard… - International Journal of …, 2010 - Elsevier
OBJECTIVES: Hepatitis B virus (HBV), hepatitis C virus (HCV), and the human
immunodeficiency virus (HIV) are endemic in Africa. However, hepatitis co-infection rates …
immunodeficiency virus (HIV) are endemic in Africa. However, hepatitis co-infection rates …
Increased detection of HBV DNA in HBsAg‐positive and HBsAg‐negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary …
This retrospective study investigated the prevalence of hepatitis B virus (HBV) in 192 stored
sera from human immunodeficiency virus (HIV) positive South African patients initiating …
sera from human immunodeficiency virus (HIV) positive South African patients initiating …
[HTML][HTML] The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa
Objectives Persistent hepatitis B virus (HBV) infection is a major cause of morbidity and
mortality in sub-Saharan Africa. The HIV epidemic has the potential to affect its biology …
mortality in sub-Saharan Africa. The HIV epidemic has the potential to affect its biology …
Prevention of materno‐foetal transmission of hepatitis B in sub‐Saharan Africa: the evidence, current practice and future challenges
Hepatitis B (HBV) infection is highly endemic in sub‐Saharan Africa (SSA), where more than
8% of the population remain chronic HBV carriers. SSA has one of the highest HBV‐related …
8% of the population remain chronic HBV carriers. SSA has one of the highest HBV‐related …
An update after 16 years of hepatitis B vaccination in South Africa
RJ Burnett, A Kramvis, C Dochez, A Meheus - Vaccine, 2012 - Elsevier
Hepatitis B (HB) virus (HBV) infection is highly endemic with at least 65 million chronic HB
surface antigen (HBsAg) carriers in Africa, 25% of whom are expected to die from liver …
surface antigen (HBsAg) carriers in Africa, 25% of whom are expected to die from liver …
Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt–that is the question
TG Bell, E Makondo, NA Martinson, A Kramvis - 2012 - journals.plos.org
Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) share transmission routes
and are endemic in sub-Saharan Africa. The objective of the present study was to use the …
and are endemic in sub-Saharan Africa. The objective of the present study was to use the …
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
R Hecht, L Hiebert, WC Spearman… - Health policy and …, 2018 - academic.oup.com
Even though WHO has approved global goals for hepatitis elimination, most countries have
yet to establish programs for hepatitis B and C, which account for 320 million infections and …
yet to establish programs for hepatitis B and C, which account for 320 million infections and …